Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Liabilities from Discontinued Operations (2018 - 2021)

Avalo Therapeutics filings provide 4 years of Liabilities from Discontinued Operations readings, the most recent being 10000.0 for Q3 2021.

  • On a quarterly basis, Liabilities from Discontinued Operations fell 99.83% to 10000.0 in Q3 2021 year-over-year; TTM through Sep 2021 was 10000.0, a 99.83% decrease, with the full-year FY2020 number at 1341000.0, down 23.59% from a year prior.
  • Liabilities from Discontinued Operations hit 10000.0 in Q3 2021 for Avalo Therapeutics, down from 98000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 7549631.0 in Q4 2018 to a low of 10000.0 in Q3 2021.
  • Median Liabilities from Discontinued Operations over the past 4 years was 1755000.0 (2019), compared with a mean of 3195086.56.
  • Biggest five-year swings in Liabilities from Discontinued Operations: dropped 23.59% in 2020 and later crashed 99.83% in 2021.
  • Avalo Therapeutics' Liabilities from Discontinued Operations stood at 7549631.0 in 2018, then plummeted by 76.75% to 1755000.0 in 2019, then decreased by 23.59% to 1341000.0 in 2020, then plummeted by 99.25% to 10000.0 in 2021.
  • The last three reported values for Liabilities from Discontinued Operations were 10000.0 (Q3 2021), 98000.0 (Q2 2021), and 209000.0 (Q1 2021) per Business Quant data.